Zeaxantină (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zeaxantină" in Romanian language version.

refsWebsite

Global rank Romanian rank

23nih.gov

4^th place

21doi.org

2^nd place

3^rd place

2worldcat.org

5^th place

11^th place

1encyclopedia.com

462^nd place

429^th place

1oregonstate.edu

2,041^st place

1,034^th place

1web.archive.org

1^st place

1cochranelibrary.com

low place

1fda.gov

447^th place

173^rd place

1pnas.org

1,293^rd place

731^st place

1self.com

3,723^rd place

7,470^th place

cochranelibrary.com

Evans, J. R.; Lawrenson, J. G. (2017). „Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration”. The Cochrane Database of Systematic Reviews. 7: CD000254. doi:10.1002/14651858.CD000254.pub4. PMID 28756618.

doi.org

Age-Related Eye Disease Study 2 Research Group (2013). „Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial”. JAMA. 309 (19): 2005–15. doi:10.1001/jama.2013.4997. PMID 23644932.
Pinazo-Durán, M. D.; Gómez-Ulla, F; Arias, L; et al. (2014). „Do Nutritional Supplements Have a Role in Age Macular Degeneration Prevention?”. Journal of Ophthalmology. 2014: 1–15. doi:10.1155/2014/901686. PMC 3941929 . PMID 24672708.
Koo, E; Neuringer, M; Sangiovanni, J. P. (2014). „Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration”. American Journal of Clinical Nutrition. 100 (Supplement 1): 336S–346S. doi:10.3945/ajcn.113.071563. PMC 4144106 . PMID 24829491.
Nolan, J. M.; Meagher, K; Kashani, S; Beatty, S (2013). „What is meso-zeaxanthin, and where does it come from?”. Eye. 27 (8): 899–905. doi:10.1038/eye.2013.98. PMC 3740325 . PMID 23703634.
Li, B; Vachali, P; Bernstein, P. S. (2010). „Human ocular carotenoid-binding proteins”. Photochemical & Photobiological Sciences. 9 (11): 1418–25. doi:10.1039/c0pp00126k. PMC 3938892 . PMID 20820671.
Scaife, Mark A.; Ma, Cynthia A.; Ninlayarn, Thanyanun; et al. (22 mai 2012). „Comparative Analysis of β-Carotene Hydroxylase Genes for Astaxanthin Biosynthesis”. Journal of Natural Products. 75 (6): 1117–24. doi:10.1021/np300136t. PMID 22616944.
Bernstein, P. S.; Li, B; Vachali, P. P.; et al. (2015). „Lutein, Zeaxanthin, and meso-Zeaxanthin: The Basic and Clinical Science Underlying Carotenoid-based Nutritional Interventions against Ocular Disease”. Progress in Retinal and Eye Research. 50: 34–66. doi:10.1016/j.preteyeres.2015.10.003. PMC 4698241 . PMID 26541886.
„Nutritional supplements for age-related macular degeneration”. Current Opinion in Ophthalmology. 21 (3): 184–9. mai 2010. doi:10.1097/ICU.0b013e32833866ee. PMC 2909501 . PMID 20216418.
„The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22”. Archives of Ophthalmology. 125 (9): 1225–1232. septembrie 2007. doi:10.1001/archopht.125.9.1225. PMID 17846363.
„Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration”. Invest. Ophthalmol. Vis. Sci. 56 (1): 252–8. 2014. doi:10.1167/iovs.14-15553. PMID 25515572.
„Role of lutein supplementation in the management of age-related macular degeneration: meta-analysis of randomized controlled trials”. Ophthalmic Res. 52 (4): 198–205. 2014. doi:10.1159/000363327. PMID 25358528.
„Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis”. Br. J. Nutr. 107 (3): 350–9. 2012. doi:10.1017/S0007114511004260. PMID 21899805.
Evans, J. R.; Lawrenson, J. G. (2017). „Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration”. The Cochrane Database of Systematic Reviews. 7: CD000254. doi:10.1002/14651858.CD000254.pub4. PMID 28756618.
„Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis”. Nutrients. 6 (1): 452–65. 2014. doi:10.3390/nu6010452. PMC 3916871 . PMID 24451312.
„A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract”. Graefes Arch. Clin. Exp. Ophthalmol. 252 (1): 63–70. 2014. doi:10.1007/s00417-013-2492-3. PMID 24150707.
„Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4”. JAMA Ophthalmol. 131 (7): 843–50. 2013. doi:10.1001/jamaophthalmol.2013.4412. PMID 23645227.
„Nutrition and the prevention of cataracts”. Current Opinion in Ophthalmology. 19 (1): 66–70. ianuarie 2008. doi:10.1097/ICU.0b013e3282f2d7b6. PMID 18090901.
„Scientific Opinion on the substantiation of a health claim related to a combination of lutein and zeaxanthin and improved vision under bright light conditions pursuant to Article 13(5) of Regulation (EC) No 1924/2006”. EFSA Journal. 12 (7): 3753. 2014. doi:10.2903/j.efsa.2014.3753. ISSN 1831-4732.
Yu, B.; Wang, J.; Suter, P. M.; et al. (2012). „Spirulina is an effective dietary source of zeaxanthin to humans”. British Journal of Nutrition. 108 (4): 611–619. doi:10.1017/S0007114511005885. PMID 22313576.
Frusciante, Sarah; Diretto, Gianfranco; Bruno, Mark; et al. (19 august 2014). „Novel carotenoid cleavage dioxygenase catalyzes the first dedicated step in saffron crocin biosynthesis”. Proceedings of the National Academy of Sciences (în engleză). 111 (33): 12246–12251. doi:10.1073/pnas.1404629111. ISSN 0027-8424. PMC 4143034 . PMID 25097262.
„Zeaxanthin: Review of Toxicological Data and Acceptable Daily Intake”. Journal of Ophthalmology. 2016: 1–15. 2016. doi:10.1155/2016/3690140. PMC 4738691 . PMID 26885380.
• In their evaluation of the safety of synthetic zeaxanthin as a Novel Food, the EFSA NDA Scientific Panel [37] applied a 200-fold safety factor to this NOAEL to define an ADI of 0.75 mg/kg bw/day, or 53 mg/day for a 70 kg adult.
• Formulated zeaxanthin was not mutagenic or clastogenic in a series of in vitro and in vivo tests for genotoxicity.
• Information from human intervention studies also supports that an intake higher than 2 mg/day is safe, and an intake level of 20 mg/day for up to 6 months was without adverse effect.

encyclopedia.com

Encyclopedia.com. „Carotenoids”. Accesat în 6 mai 2012.

fda.gov

„Letter of Denial - Xangold Lutein Esters, Lutein, or Zeaxanthin and Reduced Risk of Age-related Macular Degeneration or Cataract Formation (Docket No. 2004Q-0180”. US FDA, Qualified Health Claims. 19 decembrie 2005.

nih.gov

ncbi.nlm.nih.gov

Age-Related Eye Disease Study 2 Research Group (2013). „Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial”. JAMA. 309 (19): 2005–15. doi:10.1001/jama.2013.4997. PMID 23644932.
Pinazo-Durán, M. D.; Gómez-Ulla, F; Arias, L; et al. (2014). „Do Nutritional Supplements Have a Role in Age Macular Degeneration Prevention?”. Journal of Ophthalmology. 2014: 1–15. doi:10.1155/2014/901686. PMC 3941929 . PMID 24672708.
Koo, E; Neuringer, M; Sangiovanni, J. P. (2014). „Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration”. American Journal of Clinical Nutrition. 100 (Supplement 1): 336S–346S. doi:10.3945/ajcn.113.071563. PMC 4144106 . PMID 24829491.
Nolan, J. M.; Meagher, K; Kashani, S; Beatty, S (2013). „What is meso-zeaxanthin, and where does it come from?”. Eye. 27 (8): 899–905. doi:10.1038/eye.2013.98. PMC 3740325 . PMID 23703634.
Li, B; Vachali, P; Bernstein, P. S. (2010). „Human ocular carotenoid-binding proteins”. Photochemical & Photobiological Sciences. 9 (11): 1418–25. doi:10.1039/c0pp00126k. PMC 3938892 . PMID 20820671.
Scaife, Mark A.; Ma, Cynthia A.; Ninlayarn, Thanyanun; et al. (22 mai 2012). „Comparative Analysis of β-Carotene Hydroxylase Genes for Astaxanthin Biosynthesis”. Journal of Natural Products. 75 (6): 1117–24. doi:10.1021/np300136t. PMID 22616944.
Bernstein, P. S.; Li, B; Vachali, P. P.; et al. (2015). „Lutein, Zeaxanthin, and meso-Zeaxanthin: The Basic and Clinical Science Underlying Carotenoid-based Nutritional Interventions against Ocular Disease”. Progress in Retinal and Eye Research. 50: 34–66. doi:10.1016/j.preteyeres.2015.10.003. PMC 4698241 . PMID 26541886.
„Nutritional supplements for age-related macular degeneration”. Current Opinion in Ophthalmology. 21 (3): 184–9. mai 2010. doi:10.1097/ICU.0b013e32833866ee. PMC 2909501 . PMID 20216418.
„The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22”. Archives of Ophthalmology. 125 (9): 1225–1232. septembrie 2007. doi:10.1001/archopht.125.9.1225. PMID 17846363.
„Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration”. Invest. Ophthalmol. Vis. Sci. 56 (1): 252–8. 2014. doi:10.1167/iovs.14-15553. PMID 25515572.
„Role of lutein supplementation in the management of age-related macular degeneration: meta-analysis of randomized controlled trials”. Ophthalmic Res. 52 (4): 198–205. 2014. doi:10.1159/000363327. PMID 25358528.
„Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis”. Br. J. Nutr. 107 (3): 350–9. 2012. doi:10.1017/S0007114511004260. PMID 21899805.
Evans, J. R.; Lawrenson, J. G. (2017). „Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration”. The Cochrane Database of Systematic Reviews. 7: CD000254. doi:10.1002/14651858.CD000254.pub4. PMID 28756618.
„Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis”. Nutrients. 6 (1): 452–65. 2014. doi:10.3390/nu6010452. PMC 3916871 . PMID 24451312.
„A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract”. Graefes Arch. Clin. Exp. Ophthalmol. 252 (1): 63–70. 2014. doi:10.1007/s00417-013-2492-3. PMID 24150707.
„Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4”. JAMA Ophthalmol. 131 (7): 843–50. 2013. doi:10.1001/jamaophthalmol.2013.4412. PMID 23645227.
„Nutrition and the prevention of cataracts”. Current Opinion in Ophthalmology. 19 (1): 66–70. ianuarie 2008. doi:10.1097/ICU.0b013e3282f2d7b6. PMID 18090901.
Yu, B.; Wang, J.; Suter, P. M.; et al. (2012). „Spirulina is an effective dietary source of zeaxanthin to humans”. British Journal of Nutrition. 108 (4): 611–619. doi:10.1017/S0007114511005885. PMID 22313576.
Frusciante, Sarah; Diretto, Gianfranco; Bruno, Mark; et al. (19 august 2014). „Novel carotenoid cleavage dioxygenase catalyzes the first dedicated step in saffron crocin biosynthesis”. Proceedings of the National Academy of Sciences (în engleză). 111 (33): 12246–12251. doi:10.1073/pnas.1404629111. ISSN 0027-8424. PMC 4143034 . PMID 25097262.
„Zeaxanthin: Review of Toxicological Data and Acceptable Daily Intake”. Journal of Ophthalmology. 2016: 1–15. 2016. doi:10.1155/2016/3690140. PMC 4738691 . PMID 26885380.
• In their evaluation of the safety of synthetic zeaxanthin as a Novel Food, the EFSA NDA Scientific Panel [37] applied a 200-fold safety factor to this NOAEL to define an ADI of 0.75 mg/kg bw/day, or 53 mg/day for a 70 kg adult.
• Formulated zeaxanthin was not mutagenic or clastogenic in a series of in vitro and in vivo tests for genotoxicity.
• Information from human intervention studies also supports that an intake higher than 2 mg/day is safe, and an intake level of 20 mg/day for up to 6 months was without adverse effect.

pubchem.ncbi.nlm.nih.gov

„Zeaxantină”, Zeaxanthin (în engleză), PubChem, accesat în 19 noiembrie 2016
„Zeaxantină”, Zeaxanthin (în engleză), PubChem, accesat în 5 octombrie 2016

nei.nih.gov

„NIH study provides clarity on supplements for protection against blinding eye disease”. US National Eye Institute, National Institutes of Health, Bethesda, MD. 5 mai 2013. Arhivat din original la 15 august 2019. Accesat în 10 august 2017.

oregonstate.edu

lpi.oregonstate.edu

„Lutein + Zeaxanthin Content of Selected Foods”. Linus Pauling Institute, Oregon State University, Corvallis. 2014. Accesat în 20 mai 2014.

pnas.org

Frusciante, Sarah; Diretto, Gianfranco; Bruno, Mark; et al. (19 august 2014). „Novel carotenoid cleavage dioxygenase catalyzes the first dedicated step in saffron crocin biosynthesis”. Proceedings of the National Academy of Sciences (în engleză). 111 (33): 12246–12251. doi:10.1073/pnas.1404629111. ISSN 0027-8424. PMC 4143034 . PMID 25097262.

self.com

nutritiondata.self.com

„Foods highest in lutein-zeaxanthin per 100 grams”. Conde Nast for the USDA National Nutrient Database, release SR-21. 2014. Accesat în 23 decembrie 2015.

web.archive.org

„NIH study provides clarity on supplements for protection against blinding eye disease”. US National Eye Institute, National Institutes of Health, Bethesda, MD. 5 mai 2013. Arhivat din original la 15 august 2019. Accesat în 10 august 2017.

worldcat.org

„Scientific Opinion on the substantiation of a health claim related to a combination of lutein and zeaxanthin and improved vision under bright light conditions pursuant to Article 13(5) of Regulation (EC) No 1924/2006”. EFSA Journal. 12 (7): 3753. 2014. doi:10.2903/j.efsa.2014.3753. ISSN 1831-4732.
Frusciante, Sarah; Diretto, Gianfranco; Bruno, Mark; et al. (19 august 2014). „Novel carotenoid cleavage dioxygenase catalyzes the first dedicated step in saffron crocin biosynthesis”. Proceedings of the National Academy of Sciences (în engleză). 111 (33): 12246–12251. doi:10.1073/pnas.1404629111. ISSN 0027-8424. PMC 4143034 . PMID 25097262.